Literature DB >> 17160943

[Analysis of cholesterol ester transfer protein gene Taq IB and -629 C/A polymorphisms in patients with endogenous hypertriglyceridemia in Chinese population].

Yin Wu1, Huai Bai, Rui Liu, Yu Liu, Bing-wen Liu.   

Abstract

OBJECTIVE: To investigate the variations of cholesterol ester transfer protein (CETP) gene and its relation to endogenous hypertriglyceridemia (HTG) in Chinese population.
METHODS: One hundred and thirty-five endogenous hypertriglyceridemics and 214 healthy subjects from a population of Chinese Han nationality in Chengdu area were studied using restriction fragment length polymorphism (RFLPs) amplified by polymerase chain reaction (PCR). The polymorphic sites studied included Taq IB and -629 C/A polymorphism in CETP gene.
RESULTS: The frequencies of B(2) allele at Taq IB site in normal group and HTG group were 0.418 and 0.382, respectively. The frequencies of A allele at -629 C/A site in the two groups were 0.479 and 0.489, respectively. No significant difference between normal control and HTG groups were found in both allele frequency of the two polymorphism. Linkage disequilibrium was observed between Taq IB and -629 C/A polymorphic sites (D'=0.881). In the normal control group, subjects with genotype B(2)B(2) of Taq IB site had a higher serum mean concentration of HDL-C and lower LDL-C when compared with that of genotype B(1)B(1) and B(1)B(2), respectively (both P< 0.05), while those with genotype CC of -629 C/A site had a lower LDL-C level and higher Apo A II level when compared with that of genotype AC (P< 0.01 and P< 0.05, respectively). The changes of the lipid and lipoprotein levels were only observed in normal male subjects when male and female groups were further separated. No significant changes of lipid and lipoprotein levels were observed in both polymorphism in HTG group. Combined genotype analysis of the two sites, subjects with genotype B(2)B(2)CC in normal controls had higher HDL-C levels but lower serum triglyceride (TG) when compared with B(1)B(1)CC.
CONCLUSION: These results suggest that Taq IB and -629 C/A polymorphisms in CETP gene are associated with healthy control subjects to some extent in Chinese population, but not with endogenous hypertriglyleridemia in the population group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160943

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  5 in total

1.  Resequencing of the CETP gene in American whites and African blacks: Association of rare and common variants with HDL-cholesterol levels.

Authors:  Dilek Pirim; Xingbin Wang; Vipavee Niemsiri; Zaheda H Radwan; Clareann H Bunker; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  Metabolism       Date:  2015-09-30       Impact factor: 8.694

2.  Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease.

Authors:  Guo-Long Gu; Xiao-Lin Xu; Qing-You Yang; Ruo-Long Zeng
Journal:  Med Sci Monit       Date:  2014-12-30

3.  Association of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population.

Authors:  Yongjian Lu; Naeimeh Tayebi; Hongzhe Li; Nilmani Saha; Hongyuan Yang; Chew-Kiat Heng
Journal:  Lipids Health Dis       Date:  2013-06-08       Impact factor: 3.876

4.  Association of I405V polymorphism of colesteryl ester transfer protein gene with coronary artery disease in men with type 2 diabetes.

Authors:  Fatameh Karimpour; Ghorban Mohammadzadeh; Alireza Kheirollah; Mohammad Ali Ghaffari; Azadeh Saki
Journal:  ARYA Atheroscler       Date:  2016-03

5.  Logic Regression Analysis of Gene Polymorphisms and HDL Levels in a Nationally Representative Sample of Iranian Adolescents: The CASPIAN-III Study.

Authors:  Mehri Moghadasi; Roya Kelishadi; Hamid Reza Marateb; Shaghayegh Haghjooy Javanmard; Marjan Mansourian; Ramin Heshmat; Mohammad Esmaeil Motlagh
Journal:  Int J Endocrinol Metab       Date:  2017-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.